Erector Spinae Plane Block for Postoperative Pain Control in Hip Replacement Surgeries

Bassant M. Abdelhamid

Status: Completed

Conditions: Postoperative Pain

Treatments: Procedure: ultrasound-guided Erector spinae plane block; Procedure: subarachonoid block

Study type: Interventional

Funder types: Other

Identifiers

NCT04003909

N-147-2018

Details and patient eligibility

About

ESP block advantages include its simplicity, easy identifiable ultrasonographic landmarks and low risk for serious complications as injection is into tissue plane that is distant from pleura, major blood vessels and discrete nerves. Coupled with the fact that the erector spinae muscle and ESP extend down to the lumbar spine, ESP block was hypothesized to be performed at the level of L4. In a recent case report, ultrasound guided ESP block was successfully performed at L4 transverse process level for postoperative analgesia after total hip arthroplasty. However, confirmation of the efficacy of ESP block in hip replacement surgeries needed more investigation.

Full description

This study will be performed in Cairo university hospital. Thirty adult patients of both sexes scheduled for hip replacement surgery under spinal anesthesia will be enrolled in the study.

All patients meeting the inclusion criteria will be randomly assigned to one of 2 groups, 15 per group:

Group E, ESP group (n=15): prior to surgical incision, patients will have ultrasound guided ESP block before spinal anesthesia.

Group C, Control group (n=15): prior to surgical incision, patients will have spinal Anesthesia without ESP block .

Patients will be randomly allocated by a computer-generated table into one of the study groups, the randomization sequence will be concealed in sealed opaque envelopes.

Enrollment: 30 patients

Sex: All

Ages: 18 to 65 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients aged from 40 to 65 years old
• Both sexes.
• ASA I-II.
• Undergo hip replacement surgery.
• Body mass index (BMI) from 18 to 35 kg/m2.

Exclusion criteria

• Patient refusal.
• Contraindication to regional anesthesia (bleeding disorder, use of any anticoagulants, local infection, etc. )
• BMI > 35.
• Known allergy to local anesthetics.
• ASA III-IV.
• Patients with difficulty in evaluating their level of pain.

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Single Blind

---

30 participants in 2 patient groups

ESP group

Experimental group

Description:

patients will have ultrasound guided ESP block before spinal anesthesia.

Treatment:

Procedure: subarachonoid block

Procedure: ultrasound-guided Erector spinae plane block

Control group

Experimental group

Description:

patients will have spinal Anesthesia without ESP block

Treatment:

Procedure: subarachonoid block